Fundraising Fox
/People
Sign in

Bruce Booth

InvestorUnicorn founder

Chair at Kymera Therapeutics · Partner at Atlas Venture

Wellesley, MA

Writes $500K – $5M checks · typically $2M

FoundedKymera Therapeutics$2.3B

Find your path to Bruce

Sign up to see every warm intro you have to Bruce

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Bruce. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Bruce Booth is a partner at Atlas Venture focused on the discovery and development of novel medicines and therapeutic platforms. He joined Atlas in 2005 after working as a consultant at McKinsey & Company and as an investor for Caxton Health Holdings. He holds a D.Phil. in molecular immunology from Oxford University, which he attended as a British Marshall Scholar, and a BS in biochemistry from The Pennsylvania State University.

Contact· published on Bruce's own website

Invests in

Biotech

Chair at Kymera Therapeutics

Intro paths

→

In turn, Bruce can intro founders to Kymera Therapeutics's investors below.

Kymera Therapeutics's investors · 14

6 Dimensions CapitalGrand Cayman · since 2018Atlas VentureCambridge · $500K – $1M checksAvoro Capital AdvisorsNew YorkBain Capital Life SciencesBostonBessemer Venture PartnersSan Francisco · $50K – $100M checksBiotechnology Value FundSan FranciscoHatteras Venture PartnersResearch Triangle · $500K – $4M checksMRL Ventures FundCambridge · $25M checksNextech InvestZurich · $648K – $3.2M checksPfizer Venture Investments$5M – $20M checksREDMILESan FranciscoSanofi VenturesCambridge · $5M checksSolasta VenturesBostonWellington ManagementBoston · $5M – $50M checks

Co-founders at Kymera Therapeutics

NMNello Mainolfi
Nello MainolfiFounder

Investments

Board seats

AvilaHotspot TherapeuticsKymera TherapeuticsLifordi ImmunotherapeuticsLysosomal TherapeuticsMatchpoint TherapeuticsNimbus LakshmiPadlock TherapeuticsRodin TherapeuticsSionna TherapeuticsSpolia TherapeuticsStromedixVigil Neuroscience

Investor

Arkuda TherapeuticsAvila TherapeuticsAvrobioBicycle TherapeuticsCogent BiosciencesHotSpot TherapeuticsKymera TherapeuticsLarimar TherapeuticsLifordi ImmunotherapeuticsLysosomal TherapeuticsMagenta TherapeuticsMatchpoint TherapeuticsNimbus TherapeuticsNumeratePadlock TherapeuticsQuartet MedicineQuench BioRodin TherapeuticsSionna TherapeuticsStromedixViridian Therapeutics (Formerly MiRagen Therapeutics)

Sources: the firm's website · curated public sources.

Colleagues at Atlas Venture

Aimee Raleigh
Principal at Atlas Venture
Akshay Vaishnaw
Venture Partner at Atlas Venture
Alex Harding
Entrepreneur-in-Residence; Chief Executive Officer, Stealth NewCo at Atlas Venture
Alex Lugovskoy
Atlas Advisor; Chief Executive Officer, Diagonal Therapeutics at Atlas Venture
Alfica Sehgal
Entrepreneur-in-Residence; Chief Scientific Officer, Judo Bio at Atlas Venture
Andrea DiMella
Senior Vice President, Head of Talent at Atlas Venture
Angela Lam
Executive Assistant at Atlas Venture
Bruce Booth, DPhil
Partner at Atlas Venture

Network7

Bill Gates
Co-founder of Microsoft; Chair of the Gates Foundation
Aimee Raleigh
Principal at Atlas Venture
Chelsea Johnson
Principal at Atlas Venture
Christopher Colecchi
Managing Director at Broadview Ventures
David Grayzel
Partner at Atlas Venture
Fred Destin
Founder at Stride VC
Jason Rhodes
Partner at Atlas Venture

Investors connected to Bruce in public investor directories — a warm-intro map.

Frequently asked questions

Who is Bruce Booth?
Bruce Booth is a partner at Atlas Venture focused on the discovery and development of novel medicines and therapeutic platforms. He joined Atlas in 2005 after working as a consultant at McKinsey & Company and as an investor for Caxton Health Holdings. He holds a D.Phil. in molecular immunology from Oxford University, which he attended as a British Marshall Scholar, and a BS in biochemistry from The Pennsylvania State University.
Where does Bruce Booth work?
Bruce Booth is Chair of Kymera Therapeutics and Partner at Atlas Venture.
What does Bruce Booth invest in?
Bruce Booth invests in Biotech.
What check size does Bruce Booth write?
Bruce Booth typically writes checks of $500K – $5M.
What companies did Bruce Booth found?
Bruce Booth founded Kymera Therapeutics.
What boards does Bruce Booth sit on?
Bruce Booth holds tracked board seats at Avila, Hotspot Therapeutics, Kymera Therapeutics, Lifordi Immunotherapeutics, Lysosomal Therapeutics, Matchpoint Therapeutics, Nimbus Lakshmi, Padlock Therapeutics, Rodin Therapeutics, Sionna Therapeutics.
What companies has Bruce Booth invested in?
Investments tracked here include Arkuda Therapeutics, Avila Therapeutics, Avrobio, Bicycle Therapeutics, Cogent Biosciences, HotSpot Therapeutics, Kymera Therapeutics, Larimar Therapeutics, Lifordi Immunotherapeutics, Lysosomal Therapeutics, Magenta Therapeutics, Matchpoint Therapeutics, and 9 more.

Founder mafias

miRagen Therapeutics mafia2

Also came through, then founded or led a company.

Kyle LefkoffDirectorFounded Ambrosiabiosciences +1

About this profile. Compiled from public sources — Atlas Venture's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights